123 related articles for article (PubMed ID: 2790680)
1. Proliferative activity of early gastric cancer measured by in vitro and in vivo bromodeoxyuridine labeling.
Kamata T; Yonemura Y; Sugiyama K; Ooyama S; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Cancer; 1989 Oct; 64(8):1665-8. PubMed ID: 2790680
[TBL] [Abstract][Full Text] [Related]
2. Relation of proliferative activity to survival in patients with gastric carcinoma.
Tonemura Y; Kamata T; Ooyama S; Sugiyama K; Kimura H; Kosaka T; Yamaguchi A; Miyazaki I
J Surg Oncol; 1990 Jan; 43(1):3-7. PubMed ID: 2296193
[TBL] [Abstract][Full Text] [Related]
3. [Bromodeoxyuridine labeling index in gastric cancer].
Kamata T; Yonemura Y; Sugiyama K; Ooyama S; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1718-21. PubMed ID: 2480515
[TBL] [Abstract][Full Text] [Related]
4. Correlation of DNA ploidy and proliferative activity in human gastric cancer.
Yonemura Y; Sugiyama K; Fujimura T; De Aretxabala X; Kamata T; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Cancer; 1988 Oct; 62(8):1497-502. PubMed ID: 3167767
[TBL] [Abstract][Full Text] [Related]
5. [Proliferative activity as a marker for lymph node metastases on early gastric cancers--in vitro bromodeoxyuridine labeling for clinical use].
Ohyama S; Yonemura Y; Kamata T; Kosaka T; Yamaguchi A; Kouichi ; Miwa ; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):354-9. PubMed ID: 2359392
[TBL] [Abstract][Full Text] [Related]
6. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity].
Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1175-80. PubMed ID: 3054478
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell proliferation in early gastric cancer: biological and clinical behavior.
Dionigi P; Ferrari A; Jemos V; Luinetti O; Vai L; Guizzetti M; Ferrari C; Jemos K; Spada M; Mazzini G
Hepatogastroenterology; 2004; 51(55):264-8. PubMed ID: 15011882
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative prediction of gastric cancer development by in vitro labelling index of bromodeoxyuridine].
Sugiyama K; Yonemura Y; Takamura H; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1993 Apr; 20(6):796-8. PubMed ID: 8489287
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
Kang SM; Kim WH; Kim CW; Kim YI
J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
[TBL] [Abstract][Full Text] [Related]
10. Relation of proliferative activity to survival in patients with advanced gastric cancer.
Yonemura Y; Kamata T; Ohoyama S; Matumoto H; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Anal Cell Pathol; 1991 Mar; 3(2):103-10. PubMed ID: 2025600
[TBL] [Abstract][Full Text] [Related]
11. [Malignancy in gastric cancer, with special reference to the distribution of BrdU-labelled cells].
Kamata T; Yonemura Y; Oyama S; Sugiyama K; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):335-9. PubMed ID: 2359389
[TBL] [Abstract][Full Text] [Related]
12. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
[TBL] [Abstract][Full Text] [Related]
13. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
14. Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively?
Park SS; Kang SH; Park JM; Kim JH; Oh SC; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
Ann Surg Oncol; 2007 Jan; 14(1):94-9. PubMed ID: 17063305
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application.
Ohyama S; Yonemura Y; Miyazaki I
Cancer; 1992 Jan; 69(2):314-21. PubMed ID: 1728362
[TBL] [Abstract][Full Text] [Related]
16. Cell kinetic study of human carcinomas using bromodeoxyuridine.
Kikuyama S; Kubota T; Watanabe M; Ishibiki K; Abe O
Cell Tissue Kinet; 1988 Jan; 21(1):15-20. PubMed ID: 3056618
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of gastric adenoma versus early gastric cancer by bromodeoxyuridine immunohistochemistry from gastric biopsy specimen.
Miwa H; Wada R; Abe H; Ohkura R; Yang SW; Watanabe H; Ogihara T; Hamada T; Sato N
J Gastroenterol Hepatol; 1993; 8(2):133-7. PubMed ID: 8471750
[TBL] [Abstract][Full Text] [Related]
18. Correlation between iododeoxyuridine and MIB-1 labelling index in gastric carcinoma and adjacent normal gastric tissue.
Schipper DL; Wagenmans MJ; Peters WH; Wobbes T; Wagener DJ
Anticancer Res; 2000; 20(2A):707-14. PubMed ID: 10810344
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of proliferative activity in gastric biopsy specimens by combined BrdU and DNA polymerase alpha immunohistochemistry].
Isetani K; Hosokawa Y; Wakabayashi N; Tokita K; Mitsufuji S; Maruyama K; Kodama T; Kashima K; Tsuchihashi Y
Nihon Shokakibyo Gakkai Zasshi; 1993 Feb; 90(2):91-6. PubMed ID: 8464177
[TBL] [Abstract][Full Text] [Related]
20. [Lymphatic mapping and sentinel lymph node biopsy in gastric cancer].
Gretschel S; Bembenek A; Ulmer Ch; Hünerbein M; Markwardt J; Schneider U; Schlag PM
Chirurg; 2003 Feb; 74(2):132-8. PubMed ID: 12599031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]